Skip to content
News
Companies
Initiatives & Programs
Pioneering Medicines
Pioneering Intelligence
Preemptive Health & Medicine
Flagship Global Engagement
Flagship Fellowship
Pioneering Social Impact
Content
People
About
About Flagship
Process
Join Us
Open Search
Open Menu
News
News
company
Cellarity
All
Abiologics
Alltrna
Ampersand Biomedicines
Apriori Bio
Cellarity
CIBO Technologies
Cystic Fibrosis Foundation
Denali Therapeutics
Empress Therapeutics
Flagship Pioneering
Foghorn Therapeutics
Generate:Biomedicines
Harbinger Health
Inari Agriculture
Indigo Agriculture
Invaio Sciences
Korrus
KSQ Therapeutics
Metaphore Biotechnologies
Mirai Bio
Moderna
Montai Therapeutics
Novo Nordisk
Omega Therapeutics
ProFound™ Therapeutics
Prologue Medicines
Quotient Therapeutics
Repertoire® Immune Medicines
Ring Therapeutics
Sail Biomedicines
Sana Biotechnology
Seres Therapeutics
Sonata Therapeutics
Syros Pharmaceuticals
Tessera Therapeutics
Valo
Vesalius Therapeutics
YourBio Health
year
All
All
2024
2023
2022
domain
All
All
Human Health
Technologies
Sustainability
Novo Nordisk Enters into Research Collaborations with Omega Therapeutics and Cellarity on Novel Treatment Approaches for Cardiometabolic Diseases
Cellarity
,
Omega Therapeutics
01.04.2024
Cellarity Announces the Expansion of Its Partnership with Novo Nordisk to Discover and Develop a Novel Treatment in Metabolic Steatohepatitis (MASH) Using Its Innovative Platform
Cellarity
01.04.2024
Loading
Close Search
What are you looking for?
Search
Close Menu
News
Companies
Initiatives & Programs
Pioneering Medicines
Pioneering Intelligence
Preemptive Health & Medicine
Flagship Global Engagement
Flagship Fellowship
Pioneering Social Impact
Content
People
About
About Flagship
Process
Join Us
Contact
Careers
Privacy Policy
Terms of Use